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Background: Common practice at Chris Hani Baragwanath Academic Hospital (CHBAH) is to use boluses from a self-prepared, 
multi-dose phenylephrine solution to treat spinal anaesthesia-induced hypotension in patients undergoing a Caesarean section. 
The aims of this study were to determine if there was microbial contamination of the solutions and to evaluate whether healthcare 
workers adhered to appropriate labelling and aspiration practices.
Methods: A sample was collected and the labelling data were documented from the solutions found in the two obstetric theatres 
at CHBAH over a three-month period. The samples were sent to a laboratory for microbial investigation.
Results: Microbial contamination was identified in 6.4% of samples collected. The name of the solution was indicated on 100% of 
the containers and the concentration of the solution was on 96.4%. The date the solution was prepared was indicated on 74.6% 
of containers and the time the solution was prepared was on 57.3%. Only 8.2% of healthcare workers who prepared the solution 
confirmed it by placing a signature on the container. Labelling data were written directly on 100% of the containers and a spike-
device was used in 64.5% of the containers.
Conclusions: This study demonstrated microbial contamination of the solution and may indicate an infection hazard. Healthcare 
workers also did not adhere to appropriate labelling and aspiration practices. This is important for all patients from a patient 
safety perspective and the need to improve quality of care.
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Anaesthetists are responsible for the safe use of anaesthetic-
associated drugs.1 Recent studies have implicated anaesthetists 
in the transmission of pathogens to patients during regional2,3 
and general4,5 anaesthesia. Microbial contamination of multi-
dose vials6–9 and anaesthetic equipment10–13 are two of the main 
mechanisms by which patient-to-patient transmission of 
pathogens can occur in anaesthesia.14 Current infection control 
practices of anaesthetists working in developed countries falls 
short of accepted recommendations.14–17 A matter of particular 
concern is the infection risk due to unsafe injection practices that 
are associated with the use of single-dose vials for multiple 
patients18–20 and the use of multi-dose vials.6–9
International guidelines on preventing contamination of 
anaesthetic-associated medication21,22 clearly state that 
preservative-free vials are single-patient, single-dose items. 
There is, however, evidence in the literature that single-dose vials 
can be used for multiple patients if safe injection practices and 
aseptic technique are adhered to.23
The SASA Guidelines for Infection Control in Anaesthesia in 
South Africa 2014,24 which was published after completion of our 
study, states that bags or bottles containing intravenous 
solutions should never be used as a common source of supply 
for more than one patient. Spike-devices to remove fluid from 
infusion bottles or bags for several uses or patients should also 
never be used.
The correct labelling of medication in anaesthetic practice is a 
key element of safe medication administration.25 Inappropriate 
labelling of medication has been identified as a cause for 
medication administration errors in general26,27 and in anaesthetic 
practice.28–30 Anaesthetists can be held legally accountable for 
medication administration errors and the administration of 
contaminated medication.31
Common practice at Chris Hani Baragwanath Academic Hospital 
(CHBAH) is to use boluses of a self-prepared phenylephrine 
solution (referred to as the solution) to treat hypotension, due to 
the vasodilatory effects of a spinal anaesthetic, in stable patients 
undergoing a Caesarean section. This solution is usually prepared 
by adding one ampoule of phenylephrine (10 mg/ml) to 200 ml 
of fluid (normal saline or Ringer’s lactate) to produce a 
phenylephrine solution (50 ug/ml), which then acts as a multi-
dose vial that is used for multiple patients. The 200 ml intravenous 
fluid vaculitres used to prepare this solution do not contain any 
bactericidal or bacteriostatic agents. There is no evidence in the 
literature or in the package information from the manufacturer 
that phenylephrine has any anti-bacterial activity.
It has been observed that this solution is often labelled 
incorrectly, used for more than 12 h on multiple patients and 
strict aseptic technique is not always adhered to when using this 
solution as a multi-dose vial. This solution thus has the potential 
for microbial contamination.
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The aims of this study were to determine if there was microbial 
contamination of the solutions used at CHBAH and to evaluate 
whether healthcare workers adhered to appropriate labelling 
and aspiration practices with regard to the solutions.
Methods
Approval to conduct this study was obtained from the Human 
Research Ethics Committee (Medical), University of the 
Witwatersrand and other relevant authorities. A prospective, 
descriptive research design was used. Data were collected over a 
period of three months, from 1 October to 7 December 2012.
The solutions found in the two obstetric theatres at CHBAH were 
included in this study. Due to financial constraints the sample 
size of this study was limited to 110 samples and a convenience 
sampling method was used. Solutions with < 10 ml of solution 
left in the container were excluded from the study. If any breach 
in the aseptic technique used during the collection and 
transportation of the samples occurred, these samples were 
then also excluded.
Samples taken from the solutions were sent to the National 
Health Laboratory Service (NHLS) for microbiological 
investigation. The labelling data on the solution containers were 
also documented. The data collected are listed in Table 1.
All samples were collected by one author (AvdH). An aseptic 
technique was used to collect a 10 ml sample from each solution 
container. This technique included washing hands before taking 
the sample, wearing sterile gloves while collecting the sample, 
using a new needle and syringe to aspirate each sample if the 
rubber septum needed to be punctured, using a new syringe to 
aspirate each sample directly from the spike-device if such a 
device was in situ, disinfecting the rubber septum or spike of 
each container with 70% isopropyl alcohol and waiting two 
minutes after disinfection to allow for drying of the disinfectant 
before aspirating the sample.
An aerobic blood culture bottle (BacT/ALERT®, Biomereaux, SA) 
was then inoculated with the sample and used to culture the 
solutions. The labelling data on the solution containers were 
documented on a data collection form.
An attempt was made to deliver the blood culture bottles to the 
NHLS as soon as possible after sample collection. In consultation 
with a microbiologist it was decided that if there was a delay in 
transporting the sample to the laboratory it should be stored at 
room temperature (20–25°C) for not more than 12 h since there 
was a concern that extreme temperatures and prolonged delays 
could affect the bacterial growth.
The processing of the samples and identification of the 
microorganisms were done by qualified laboratory personnel 
using standard microbiological laboratory equipment and 
procedures.
Data capturing was done using a Microsoft Excel 2007® 
spreadsheet (Microsoft Corp, Redmond, WA, USA). Descriptive 
and inferential statistics were used to analyse the data. Statistical 
analysis was performed using GraphPad InStat® (GraphPad 
Software, La Jolla, CA, USA), a statistics program. A p-value 
of < 0.05 was considered as statistically significant.
Results
A total of 111 samples were collected. One sample was excluded 
from the study due to a breach in the aseptic technique. Microbial 
contamination was identified in seven (6.4%) of the 110 samples 
(95% confidence interval of 1.8% to 10.9%). The contaminating 
microorganisms are shown in Table 2.
The labelling and aspiration practice with regard to the solutions 
is shown in Table 3.
Of the solutions that had microbial contamination, six (85.7%) 
had spike-devices in situ. Using Fisher’s exact test, the association 
between the aspiration method of the solution and microbial 
contamination of the solution was not statistically significant 
(p = 0.4178) (Table 4).




Name and concentration of solution indicated
Date and time solution prepared indicated
Indication of whom prepared and checked the solution
Type of labelling method used
Method used to aspirate the solution
Table 2: Microbial contamination of the solutions
Microorganisms Number Percentage
Coagulase negative staphylococci 3 2.7
Brevundimonas vesicularis 1 0.9
Bacillus species 1 0.9
Micrococcus species 1 0.9
Pseudomonas alcaligenes 1 0.9
Total 7 6.4
Table 3: Labelling and aspiration practices
Presence of labelling and aspiration 
practice
Number Percentage
Name of solution 110 100
Concentration of solution 106 96.4
Date solution was prepared 82 74.66
Time solution was prepared 63 57.3
Healthcare worker’s signature 9 8.2
Information written directly on container 110 100
Spike-device used 71 64.5








Spike-device 6 65 71
No spike-device 1 38 39
Total 7 103 110
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Discussion
The use of multi-dose vials in general and anaesthetic practice 
remains controversial due to the risk of microbial contamination. 
Presently there are conflicting results reported in the literature 
regarding the risk of microbial contamination of multi-dose 
vials.7,9,19,23,32–39 Currently SASA does not endorse the practice of 
sharing single-dose vials between multiple patients.24,40,41
From a review of the literature the microbial contamination 
rates of multi-dose vials range from 0% to 27%.42 Recent studies 
have shown that multi-dose vials, and even single-dose vials 
used for multiple patients, can be used safely if safe injection 
and medication vial utilisation practices are adhered to.23,36–39 In 
our study seven (6.4%) of 110 samples were contaminated with 
microorganisms. This is similar to the results of Motamedifar 
et al.6 who reported a microbial contamination rate of 5.6%. It is, 
however, substantially higher than the microbial contamination 
rate of 0.9% reported by Mattner et al.9 This might not reflect 
the true microbial contamination rate since only contamination 
with aerobic bacteria was investigated in our study. Any 
microbial contamination of medication administered to 
patients poses a health risk. It is clear from our study that safe 
injection practices with regard to the solutions are not adhered 
to and that there is a relatively high risk for microbial 
contamination of the solution. This is of concern since patients 
are at risk of developing nosocomial infections when the 
solution is used.
The aerobic bacteria contaminating the solutions in this study 
include coagulase-negative staphylococci (2.7%), Brevundimonas 
vesicularis (0.9%), Bacillus species (0.9%), Micrococcus species 
(0.9%) and Pseudomonas alcaligenes (0.9%). This is similar to the 
results of Motamedifar et al.6 and Mattner et al.9 It is evident from 
the literature that the contaminating microorganisms identified 
in our study have been implicated as opportunistic pathogens 
that could lead to clinically significant infections in 
immunocompromised patients.43–47 This is especially important 
at CHBAH since a large proportion of South African patients are 
immunocompromised and susceptible to opportunistic 
infections.48
The literature shows that the inappropriate labelling of 
medication is a cause of medication administration errors in 
general26,27 and in anaesthetic practice.28–30 Labelling 
recommendations for medication containers include colour-
coded labels for different medication classes, patient name, 
patient hospital number, name of medication added to the 
container, amount of medication added, total volume of diluent 
in container, concentration of solution, date and time solution 
was prepared, signature of healthcare workers who prepared 
and checked the solution, and route of administration.25,49
In our study the name of the solution was indicated on all 110 
(100%) containers from which samples were collected. This is 
similar to the results reported by Mattner et al.9 where the 
medication type was indicated on 99.1% of multi-dose vials. The 
concentration of the solution was indicated on 106 (96.4%) of 
the 110 containers, which is similar to the 96.9% reported by 
Mattner et al.9 The date the solution was prepared was indicated 
on 82 (74.6%) of the 110 containers, which is substantially higher 
than the 50% reported by Mattner et al.9 The time the solution 
was prepared was indicated on 63 (57.3%) of the 110 containers. 
It is clear from the results of our study that the solutions are 
inappropriately labelled and that there is risk of an administration 
error when these solutions are used.
Recommendations for correct medication labelling and 
administration are that the healthcare worker who prepared the 
medication should sign the medication container.25,49 In our 
study only nine (8.2%) healthcare workers who prepared the 
solution placed a signature on the container. The majority of the 
solutions in our study were administered to patients without 
knowing who prepared the solution. This has medico-legal 
implications.
Writing directly onto the container should be avoided as the ink 
can leach from the PVC container into the intravenous fluid and 
has been shown to be toxic to animals.50–52 In our study the 
labelling data were written directly on all 110 (100%) containers 
from which samples were collected. This result shows that a 
potentially toxic solution may have been administered to 
patients.
The Association for Professionals in Infection Control and 
Epidemiology position paper on safe injection, infusion and 
medication vial practices in health care53 strongly discourages 
the use of a spike-device inserted into a medication vial septum 
because it leaves the vial vulnerable to contamination. In our 
study a spike-device was used in 71 (64.5%) of the 110 containers. 
This is substantially higher than the results reported by Mattner 
et al.9 where 41.4% of multi-dose vials had spike-devices. 
Although the association between the aspiration method of the 
solution and microbial contamination of the solution was not 
statistically significant (p = 0.4178), it must be noted that six of 
the seven contaminated solutions contained a spike-device.
An extensive research doctorate by Jansen31 that comprehensively 
addressed from a legal perspective various errors which can 
occur with regard to dispensing, preparation and administration 
of medication emphasised that healthcare workers experience a 
great deal of uncertainty with regard to their legal position and 
medication administration. Jansen31 further concluded that 
healthcare workers do not view medication administration as 
the high-risk activity that it is.
An important medication error that anaesthetists are legally 
accountable for is the administration of contaminated 
medication.31 In our study seven (6.4%) solutions were 
contaminated and these contaminated solutions were 
administered to patients. Jansen31 further stated that a healthcare 
worker should only administer medication that was appropriately 
checked by the healthcare worker. Our study did not evaluate 
whether anaesthetists checked the solutions appropriately 
when it was prepared. However, 101 (91.8%) solutions had no 
signature indicating who had prepared the solution and 
anaesthetists were aspirating and administering solutions from 
these containers.
Anaesthetists can be held legally accountable for medication 
errors. The medication errors identified in our study include 
administration of contaminated medication, failing to 
appropriately check all medication prior to administration and 
failing to adequately label medication.
Our study was contextual and focused on the microbial 
contamination and labelling of a solution prepared and used by 
anaesthetists working in the two obstetric theatres at CHBAH. 
This limits the generalisation of the results.
Due to financial constraints the sample size was limited to 110 
samples. Our study was a pilot observational study with no 
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sample size calculation for statistical power. This limits the 
conclusions that can be derived from our study.
Only microbial contamination with aerobic bacteria was 
investigated.
Only categorical data were collected and therefore the 
association between the length of time the solution was in use 
and microbial contamination of the solution could not be 
investigated.
Conclusion
Our study demonstrated microbial contamination of the solution 
and this may indicate an infection hazard. Safe injection practices 
were also not adhered to when intravenous medications were 
prepared and administered, which includes correct labelling 
practices. This is especially important at CHBAH since a large 
proportion of South African patients are immunocompromised 
and thus susceptible to opportunistic infections. An important 
medication error that anaesthetists are legally accountable for is 
the administration of contaminated medication. Furthermore, 
inappropriate labelling of medications is a cause of medication 
administration errors and this may have serious legal implications 
for the anaesthetist. The use of multi-dose vials in both general 
and anaesthetic practice remains controversial, and more studies 
with a larger sample size are required to establish whether this 
practice increases the risk of clinically significant infection.
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